NodThera

📍 Boston, United States🗓 Founded 2016👥 25 employees💰 Last funded Mar 2018
Biotechnology Research🌐 nodthera.com
Website LinkedIn
NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We’re building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Boston, MA; all united by our shared ambition, enthusiasm, and creativity.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
France
1
Frequently asked questions
Who invested in NodThera?
NodThera has 2 investors on record on gritt.io, including 2 early-stage backers.
When did NodThera last raise funding?
The most recent investment in NodThera recorded on gritt.io was in March 2018.
When was NodThera founded?
NodThera was founded in 2016.
What industry is NodThera in?
NodThera operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NodThera based?
NodThera is headquartered in Boston, United States.